New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bristol-Myers Squibb Company
BMY
Shape
US Flag

NYSE

EPS improving

EPS improving

105B

Drug Manufacturers - General

Next Earning date - 31 Oct 2024

105B

Drug Manufacturers - General

Next Earning date - 31 Oct 2024

51.92USD
Shape-1.00 ( -1.89%)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-40%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 27, 2024
1W -0.38 % 1M 1.47 % 3M 7.18 % 1Y 6.44 %

Key Metrics

Shape
  • Market Cap

    105.26B


  • Shares Outstanding

    2.03B


  • Share in Float

    2.03B


  • Dividende

    2.4


  • Earning Date

    31 Oct 2024


  • Price Target

    51.92


  • Average Volume

    11.96M


  • Beta

    0.46


  • Range

    39.35-55.04


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.bms.com


  • Sector

    Healthcare


Fundamentals

Shape

37.90x

P/E Ratio

2.26x

P/S Ratio

6.19x

P/B Ratio

3.1

Debt/Equity

-14.1%

Net Margin

$-3.3

EPS

How BMY compares to sector?

P/E Ratio

Relative Strength

Shape

BMY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$47B

Shape281%

2025-Revenue

$5.58

Shape572%

2025-EPS

$18B

Shape242%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bernstein

initialise

Previous: Not converted

2024-10-17

Now: Market Perform

Barclays

downgrade

Previous: Equal-Weight

2024-07-29

Now: Underweight

Deutsche Bank

initialise

Previous: Not converted

2024-01-30

Now: Hold

HSBC

upgrade

Previous: Not converted

2023-10-27

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

0%

1.99
vs 2

Q4.22

arrow
arrow

-1%

1.82
vs 1.83

Q1.23

arrow
arrow

+5%

2.05
vs 1.96

Q2.23

arrow
arrow

-9%

1.75
vs 1.93

Q3.23

arrow
arrow

+1%

2
vs 1.99

Q4.23

arrow
arrow

-7%

1.7
vs 1.82

Q1.24

arrow
arrow

N/A

-4.40
vs 2.05

Q2.24

arrow
arrow

+18%

2.07
vs 1.75

Q3.24

arrow
arrow

-22%

1.55
vs 2

Q4.24

arrow
arrow

-11%

1.51
vs 1.7

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-3%

11.2B  vs 11.6B

Q4.22

arrow
arrow

-5%

11.4B  vs 12B

Q1.23

arrow
arrow

-3%

11.3B  vs 11.6B

Q2.23

arrow
arrow

-6%

11.2B  vs 11.9B

Q3.23

arrow
arrow

-2%

11B  vs 11.2B

Q4.23

arrow
arrow

+1%

11.5B  vs 11.4B

Q1.24

arrow
arrow

+5%

11.9B  vs 11.3B

Q2.24

arrow
arrow

+9%

12.2B  vs 11.2B

Q3.24

arrow
arrow

+3%

11.3B  vs 11B

Q4.24

arrow
arrow

0%

11.5B  vs 11.5B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.04

Q4.22

arrow
arrow

+7%

0.07
vs 0.05

Q1.23

arrow
arrow

+7%

0.07
vs 0.07

Q2.23

arrow
arrow

+6%

0.06
vs 0.07

Q3.23

arrow
arrow

+7%

0.07
vs 0.06

Q4.23

arrow
arrow

+6%

0.06
vs 0.07

Q1.24

arrow
arrow

-72%

-0.72
vs 0.06

Q2.24

arrow
arrow

+10%

0.1
vs -0.72

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

2540

2.5K
vs 2.6K

-3%

Q4.22

arrow
arrow

2665

2.7K
vs 2.5K

5%

Q1.23

arrow
arrow

2596

2.6K
vs 2.7K

-3%

Q2.23

arrow
arrow

2532

2.5K
vs 2.6K

-2%

Q3.23

arrow
arrow

2438

2.4K
vs 2.5K

-4%

Q4.23

arrow
arrow

2421

2.4K
vs 2.4K

-1%

Q1.24

arrow
arrow

2383

2.4K
vs 2.4K

-2%

Q2.24

arrow
arrow

2160

2.2K
vs 2.4K

-9%

Earnings Growth

Latest News